Title |
C1q-Mediated Repression of Human Monocytes Is Regulated by Leukocyte-Associated Ig-Like Receptor 1 (LAIR-1)
|
---|---|
Published in |
Molecular Medicine, September 2014
|
DOI | 10.2119/molmed.2014.00185 |
Pubmed ID | |
Authors |
Myoungsun Son, Betty Diamond |
Abstract |
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by abnormal function of both the innate and the adaptive immune system, leading to a loss of tolerance to self-antigens. Monocytes are a key component of the innate immune system and are efficient producers of multiple cytokines. In SLE, inappropriate activation of monocytes is thought to contribute to the loss of self-tolerance. In this study, we demonstrate that type 1 interferon (IFN) production by CpG-challenged monocytes can be suppressed by C1q through activating leukocyte-associated Ig-like receptor-1 (LAIR-1), which contains immunoreceptor tyrosine-based inhibition motifs (ITIMs). The phosphorylation of LAIR-1 and the interaction of LAIR-1 with SH2 domain-containing protein tyrosine phosphatase-1 (SHP-1) were enhanced after LAIR-1 engagement by C1q. Moreover, engagement of LAIR-1 by C1q inhibited nuclear translocation of interferon regulatory factor (IRF)-3 and IRF5 in CpG-stimulated monocytes. These data suggest a model in which LAIR-1 engagement by C1q helps maintain monocyte tolerance, specifically with respect to Toll-like receptor-9-mediated monocyte activation. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 46 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 15% |
Student > Master | 6 | 13% |
Researcher | 5 | 11% |
Student > Doctoral Student | 4 | 9% |
Professor | 2 | 4% |
Other | 5 | 11% |
Unknown | 17 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 7 | 15% |
Immunology and Microbiology | 7 | 15% |
Biochemistry, Genetics and Molecular Biology | 5 | 11% |
Medicine and Dentistry | 4 | 9% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 7% |
Other | 3 | 7% |
Unknown | 17 | 37% |